Raia Drogasil S.A. (RADLY)
USD 3.37
(-4.8%)
USD 3.37
(-4.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 6.65 Billion BRL | 18.33% |
| 2022 | 5.62 Billion BRL | 16.64% |
| 2021 | 4.82 Billion BRL | 14.7% |
| 2020 | 4.2 Billion BRL | 4.79% |
| 2019 | 4.01 Billion BRL | 566.89% |
| 2018 | 601.58 Million BRL | 73.82% |
| 2017 | 346.08 Million BRL | 152.0% |
| 2016 | 137.33 Million BRL | 352.7% |
| 2015 | 30.33 Million BRL | 63102.08% |
| 2014 | 48 Thousand BRL | -99.81% |
| 2013 | 24.96 Million BRL | -0.98% |
| 2012 | 25.2 Million BRL | 115.29% |
| 2011 | -164.84 Million BRL | -372.62% |
| 2010 | 60.46 Million BRL | -72.4% |
| 2009 | 219.07 Million BRL | 1207.76% |
| 2008 | -19.77 Million BRL | -45.66% |
| 2007 | -13.57 Million BRL | -190.94% |
| 2006 | 14.92 Million BRL | 297.11% |
| 2005 | -7.57 Million BRL | -290.78% |
| 2004 | 3.97 Million BRL | 211.61% |
| 2003 | -3.55 Million BRL | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 7.21 Billion BRL | 10.31% |
| 2024 Q1 | 6.53 Billion BRL | -1.78% |
| 2023 Q1 | 5.64 Billion BRL | 0.44% |
| 2023 FY | 6.65 Billion BRL | 18.33% |
| 2023 Q3 | 6.44 Billion BRL | 8.46% |
| 2023 Q2 | 5.94 Billion BRL | 5.15% |
| 2023 Q4 | 6.65 Billion BRL | 3.3% |
| 2022 Q3 | 5.62 Billion BRL | 6.0% |
| 2022 Q4 | 5.62 Billion BRL | -0.06% |
| 2022 FY | 5.62 Billion BRL | 16.64% |
| 2022 Q1 | 5.37 Billion BRL | 11.47% |
| 2022 Q2 | 5.3 Billion BRL | -1.22% |
| 2021 FY | 4.82 Billion BRL | 14.7% |
| 2021 Q1 | 4.36 Billion BRL | 3.78% |
| 2021 Q2 | 4.85 Billion BRL | 11.36% |
| 2021 Q3 | 4.99 Billion BRL | 2.76% |
| 2021 Q4 | 4.82 Billion BRL | -3.41% |
| 2020 Q1 | 4.23 Billion BRL | 5.6% |
| 2020 FY | 4.2 Billion BRL | 4.79% |
| 2020 Q4 | 4.2 Billion BRL | -6.13% |
| 2020 Q3 | 4.47 Billion BRL | -6.27% |
| 2020 Q2 | 4.77 Billion BRL | 12.79% |
| 2019 Q4 | 4.01 Billion BRL | -12.75% |
| 2019 FY | 4.01 Billion BRL | 566.89% |
| 2019 Q1 | 1.39 Billion BRL | 131.26% |
| 2019 Q2 | 4.5 Billion BRL | 223.95% |
| 2019 Q3 | 4.59 Billion BRL | 2.03% |
| 2018 FY | 601.58 Million BRL | 73.82% |
| 2018 Q4 | 601.58 Million BRL | -14.34% |
| 2018 Q3 | 702.26 Million BRL | 0.67% |
| 2018 Q2 | 697.56 Million BRL | 29.47% |
| 2018 Q1 | 538.78 Million BRL | 55.68% |
| 2017 Q1 | 349.75 Million BRL | 154.67% |
| 2017 Q2 | 487.82 Million BRL | 39.48% |
| 2017 FY | 346.08 Million BRL | 152.0% |
| 2017 Q3 | 385.47 Million BRL | -20.98% |
| 2017 Q4 | 346.08 Million BRL | -10.22% |
| 2016 Q2 | 315.49 Million BRL | 35.76% |
| 2016 FY | 137.33 Million BRL | 352.7% |
| 2016 Q3 | 156.18 Million BRL | -50.49% |
| 2016 Q4 | 137.33 Million BRL | -12.07% |
| 2016 Q1 | 232.38 Million BRL | 666.02% |
| 2015 Q2 | 89.74 Million BRL | 51.97% |
| 2015 Q4 | 30.33 Million BRL | 15.67% |
| 2015 FY | 30.33 Million BRL | 63102.08% |
| 2015 Q1 | 59.05 Million BRL | 122920.83% |
| 2015 Q3 | 26.22 Million BRL | -70.77% |
| 2014 FY | 48 Thousand BRL | -99.81% |
| 2014 Q4 | 48 Thousand BRL | -99.95% |
| 2014 Q3 | 104.05 Million BRL | -16.72% |
| 2014 Q2 | 124.95 Million BRL | -12.07% |
| 2014 Q1 | 142.1 Million BRL | 469.29% |
| 2013 Q1 | 91.82 Million BRL | 264.25% |
| 2013 Q4 | 24.96 Million BRL | -69.03% |
| 2013 Q3 | 80.6 Million BRL | -41.59% |
| 2013 Q2 | 137.99 Million BRL | 50.28% |
| 2013 FY | 24.96 Million BRL | -0.98% |
| 2012 Q4 | 25.2 Million BRL | 136.31% |
| 2012 FY | 25.2 Million BRL | 115.29% |
| 2012 Q3 | -69.43 Million BRL | -277.58% |
| 2012 Q1 | -169.44 Million BRL | -2.79% |
| 2012 Q2 | 39.09 Million BRL | 123.08% |
| 2011 FY | -164.84 Million BRL | -372.62% |
| 2011 Q4 | -164.84 Million BRL | -707.35% |
| 2011 Q3 | 27.14 Million BRL | 2.63% |
| 2011 Q2 | 26.44 Million BRL | -76.27% |
| 2011 Q1 | 111.46 Million BRL | 84.33% |
| 2010 Q2 | -87.05 Million BRL | 0.0% |
| 2010 Q3 | 46.93 Million BRL | 153.91% |
| 2010 Q1 | - BRL | -100.0% |
| 2010 Q4 | 60.46 Million BRL | 28.83% |
| 2010 FY | 60.46 Million BRL | -72.4% |
| 2009 FY | 219.07 Million BRL | 1207.76% |
| 2009 Q4 | 219.07 Million BRL | 0.0% |
| 2008 FY | -19.77 Million BRL | -45.66% |
| 2007 FY | -13.57 Million BRL | -190.94% |
| 2006 FY | 14.92 Million BRL | 297.11% |
| 2005 FY | -7.57 Million BRL | -290.78% |
| 2004 FY | 3.97 Million BRL | 211.61% |
| 2003 FY | -3.55 Million BRL | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -1600509.686% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -301028.699% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | -111.13 Million USD | 6088.602% |
| Café Serendipity Holdings, Inc. | 409.94 Thousand USD | -1623335.266% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 271.74 Thousand USD | -2448984.787% |
| HealthWarehouse.com, Inc. | 2.17 Million USD | -306312.141% |
| LIGAND PHARMACEUTICAL INC | -16.78 Million USD | 39739.901% |
| MedGen, Inc. | 24.36 USD | -27319962954.187% |
| Omni Health, Inc. | 1.46 Million USD | -455120.906% |
| Oxford Investments Holdings Inc. | 172.66 Thousand USD | -3854200.16% |
| Pineapple, Inc. | 8.1 Million USD | -81966.292% |
| ScripsAmerica, Inc. | 748.59 Thousand USD | -888921.389% |